ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2144

Functional Analysis of Macrophages in BehçEt’s Disease: C-C Chemokine Receptor Type 1 (CCR1) and IL-10 Are Implicated in Pathogenesis of the Disease

Hiroto Nakano1, Yohei Kirino1, Momoko Ohno1, Kana Higashitani1, Mitsuhiro Takeno2, Ryusuke Yoshimi1 and Hideaki Nakajima3, 1Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Yokohama, Japan, 2Department of Allergy and Rheumatology, Nippon Medical School Graduate School of Medicine, Tokyo, Japan, 3Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, Yokohama, Japan

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Behcet's syndrome, Chemokine Receptors, interleukins (IL) and macrophages

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 15, 2016

Title: Cytokines, Mediators, Cell-Cell Adhesion, Cell Trafficking and Angiogenesis - Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

The recent GWAS and subsequent studies have identified susceptible genes such as CCR1 and IL10 genes, suggesting pathological roles of macrophages in Behçet’s disease (BD). The purpose of this study is to compare features of in vitro differentiated M1 and M2 macrophages from peripheral blood between BD and healthy controls (HC).

Methods:

Differentiations into M1 or M2 macrophages were induced in vitro from peripheral monocytes in presence of GM-CSF or M-CSF, respectively. Expressions of CD68, CD163, and CCR1 were determined by realtime PCR and flow cytometric analyses. For the macrophages that were treated with LPS for 24 hours, the supernatants were analyzed for cytokine profiles using beads assay.

Results:

Differentiated M1 macrophage produced higher amounts of IL-6 whereas, M2 macrophage secreted higher volume of IL-10. M2 macrophage has increased expression of CD163 protein and mRNA compared to M1 macrophage. CCR1 expression was increased in M2 macrophage compared to M1 macrophage (Figure 1). Cell surface CCR1 protein expression in M1 macrophage was significantly higher in BD patients compared to HC (Figure 2, t test). BD associated SNP (rs1518111) allele T is risk for decreased expression of IL10 mRNA in HC M2 macrophage.

Conclusion:

The data suggest that both susceptible CCR1 and IL10 genes are implicated in pathogenesis of BD. Further experiments including functional analyses are required to elucidate mechanisms how M1 or M2 macrophages are involved in pathogenesis of BD.


Disclosure: H. Nakano, None; Y. Kirino, None; M. Ohno, None; K. Higashitani, None; M. Takeno, None; R. Yoshimi, None; H. Nakajima, None.

To cite this abstract in AMA style:

Nakano H, Kirino Y, Ohno M, Higashitani K, Takeno M, Yoshimi R, Nakajima H. Functional Analysis of Macrophages in BehçEt’s Disease: C-C Chemokine Receptor Type 1 (CCR1) and IL-10 Are Implicated in Pathogenesis of the Disease [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/functional-analysis-of-macrophages-in-behcets-disease-c-c-chemokine-receptor-type-1-ccr1-and-il-10-are-implicated-in-pathogenesis-of-the-disease/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/functional-analysis-of-macrophages-in-behcets-disease-c-c-chemokine-receptor-type-1-ccr1-and-il-10-are-implicated-in-pathogenesis-of-the-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology